Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Anemic Earnings Growth Penalizes HMS Holdings (HMSY) Rating

By Portfolio Grader
Currently, HMS Holdings Corp (NASDAQ:HMSY) has a Hold using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking HMSY has had from Portfolio Grader for the last month.

Earnings Visibility Makes Omnicell (OMCL) a Buy

By Portfolio Grader
Portfolio Grader currently ranks Omnicell Inc (NASDAQ:OMCL) a Buy. Using Louis Navellier's investing methods, this analytical tool researches stocks by employing proprietary fundamental and quantitative metrics. The current Portfolio Grader recommendation on the shares has been in place for 3 months.

Quant Score Limits Inovalon Holding (INOV) Rating

By Portfolio Grader
Inovalon Holding Inc (NASDAQ:INOV) is a member of the 26 company Health Care Technology GICS industry group, which is a segment of the 782 company GICS Health Care sector. INOV's market value is $2.5 billion which places it in the upper half of its industry group. The ranking for INOV by Portfolio Grader places it 14 among the 26 companies in this industry group, giving it a below-average spot; in the top half of the sector with a ranking of 330 among the 782 companies in the sector, and number 2,373 in the nearly 5,000 company Portfolio Grader universe.

Earnings Growth Keeps Allscripts Healthcare Solutions (MDRX) a Sell

By Portfolio Grader
Currently, Allscripts Healthcare Solutions (NASDAQ:MDRX) has a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. This represents no change from the previous week and is the same ranking MDRX has had from Portfolio Grader for 2 months.

Tesla Inc Stock Poised for a Pullback, But Not Just Because of David Einhorn

By James Brumley, InvestorPlace Feature Writer
With Tesla trading below its 100-day moving average and scathing criticism from David Einhorn, TSLA stock may be ready for a pullback.

Cotiviti Holdings (COTV) Industry Group Rank Penalizes Rating

By Portfolio Grader
Currently, Cotiviti Holdings Inc (NYSE:COTV) has a Hold using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. The current Portfolio Grader recommendation on the shares has been in place for the last month.

Why Buffalo Wild Wings (BWLD) Stock is Flying Today

By William White, InvestorPlace Writer
Buffalo Wild Wings (BWLD) stock was soaring today on incredibly strong earnings per share for the third quarter of 2017.

Medidata Solutions’ (MDSO) Superior Sales Growth Keeps it a Buy

By Portfolio Grader
Portfolio Grader currently ranks Medidata Solutions (NASDAQ:MDSO) a Buy. Using Louis Navellier's investing methods, this analytical tool assesses stocks with fundamental and quantitative metrics. MDSO has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

Weak Earnings Growth Penalizes athenahealth (ATHN) Rating

By Portfolio Grader
Currently, athenahealth Inc (NASDAQ:ATHN) has a Hold using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. ATHN has maintained this ranking for the last month.

Bristol-Myers Squibb Co (BMY) Stock Falls on Earnings Miss

By William White, InvestorPlace Writer
Bristol-Myers Squibb (BMY) stock was down today following the release of its earnings report for the third quarter of 2017.

Earnings Visibility Makes Icon (ICLR) a Buy

By Portfolio Grader
Icon Plc (NASDAQ:ICLR) is one of 33 companies within the Life Sciences Tools & Services GICS industry group, which is in turn part of the 782 company GICS Health Care sector. ICLR has a market value of $6.1 billion which is in the upper half of its industry group. The ranking for ICLR by Portfolio Grader places it 12 among the 33 companies in this industry group, putting it in the second quartile; in the top quartile of the sector with a ranking of 150 among the 782 companies in the sector, and number 1,084 in the nearly 5,000 company Portfolio Grader universe.

Don’t Chase Helios and Matheson Analytics Inc Stock … Yet

By Charles Payne
HMNY stock will be a buy again soon, but we need to see the company earn its new valuation first. Here's what you need to know about Helios and Matheson.

SQ Stock – Square Lending Leads the Way for Massive Gains

By Aaron Levitt, InvestorPlace Contributor
While SQ stock has surged, that rise could be justified. Square's future lies with its retail management and micro-lending efforts.

Bio Rad Laboratories (BIO) a Buy on Solid Quant Score

By Portfolio Grader
Bio Rad Laboratories Inc (NYSE:BIO) ranks in the top half of its industry group, Life Sciences Tools & Services, and in the top 25% of its sector group, Health Care, with a market value of $6.6 billion. From an investment attractiveness viewpoint, BIO is ranked in the top quartile of the sector with a ranking of 99 among the 782 companies in the sector; the ranking for BIO by Portfolio Grader places it 9 among the 33 companies in this industry group, putting it in the second quartile and number 756 in the 5000 company Portfolio Grader company universe.

Ford Motor Company (F) Reports Q3 Earnings Beat

By William White, InvestorPlace Writer
Ford (F) released its earnings report for the third quarter of 2017 on Thursday and it beat EPS and revenue estimates for the quarter.

Healthy Earnings Momentum Keeps Qiagen NV (QGEN) a Buy

By Portfolio Grader
Portfolio Grader currently ranks Qiagen NV (NASDAQ:QGEN) a Buy. The methodology for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. QGEN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

Strong Quant Score Keeps PerkinElmer (PKI) a Buy

By Portfolio Grader
PerkinElmer Inc (NYSE:PKI) is ranked as a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. PKI has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

Twitter Inc (TWTR) Stock Soars on Profit Possibility

By William White, InvestorPlace Writer
Twitter's (TWTR) earnings report for the third quarter of 2017 contains some good news for investors with the possibility of profits.

Veeva Systems’ (VEEV) Solid Earnings Growth Makes it a Buy

By Portfolio Grader
Veeva Systems Inc (NYSE:VEEV) is a member of the 26 company Health Care Technology GICS industry group, which is part of the 782 company GICS Health Care sector. VEEV's market value is $8.6 billion which falls in the top 10% of its industry group. Portfolio Grader's current ranking for VEEV puts it 5 among the 26 companies in this industry group, giving it a well above-average position; in the top quartile of the sector with a ranking of 94 among the 782 companies in the sector, and number 716 in the nearly 5,000 company Portfolio Grader universe.
Load More Articles